Werewolf Therapeutics (HOWL) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.47
-0.4
-0.34
-0.27

Details

Expected EPS
-0.27
Actual EPS
-0.28
Surprise EPS
-0.01
Surprise Percent
+3.7%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.28 per share for Q2 2026.

0 Comments

Share your thoughts